Cystic Fibrosis Foundation: Achieving the mission

Respiratory Care

Volumn 54, Issue 6, 2009, Pages 788-795

  Marshall, Bruce C ^a   Penland, Chris M ^a   Hazle, Leslie ^a   Ashlock, Melissa ^a   Wetmore, Diana ^a   Campbell III, Preston W ^a   Beall, Robert J ^a  

^a CYSTIC FIBROSIS FOUNDATION   (United States)

Author keywords

Clinical trials; Cystic fibrosis; Drug discovery; Health services accessibility; Quality of health care; Registries; Respiratory therapy

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; LUNG FIBROSIS; MEDICAL EDUCATION; MEDICAL RESEARCH; NEBULIZER; NON PROFIT ORGANIZATION; PATIENT CARE; PATIENT EDUCATION; QUALITY OF LIFE; SURVIVAL;

EID: 66849106400     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: 10.4187/002013209790983223     Document Type: Conference Paper

References (8)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Registry. 2007 Annual Data Report. Bethesda, Maryland; 2008.http://www.cff.org/uploadedfiles/ research/clinicalresearch/2007-patientregistry-report.pdf. Accessed April 27, 2009.
2. Higgins RF, Kazan B, LaMontagne S. Vertex Pharmaceuticals and the cystic fibrosis foundation: venture philanthropy funding for biotech. Harvard Business Publishing. http://harvardbusiness.org. Accessed April 8, 2009.
3. Accurso FJ, Rowe SM, Durie PR, Konstan MW, Dunitz J, Hornick, et al. Interim results of phase 2a study of VX-770 to evaluate safety, pharmacokinetics, and biomarkers of CFTR activity in cystic fibrosis subjects with G551D. Pediatr Pulmonol 2008;(Supplement 31):295.
4. Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Cohen M, et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008;372(9640):719-727.
5. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998;157(6 Pt 1):1829-1832. (Pubitemid 28311266)
6. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized, controlled trial. JAMA 2003;290(13):1749-1756.
7. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey-Courand DB, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007;176(10):957-969. (Pubitemid 350127838)
8. Flume PA, Robinson KA, O'Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, White TB, et al. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54(4):522-537.